TrialJournal of acquired immune deficiency syndromes (1999)2015

Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.

David S Metzger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.